-
1
Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects
Published 2025-12-01Subjects: Get full text
Article -
2
Commentary: An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
Published 2025-04-01Subjects: “…pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
3
Abnormalities in T cell subsets in the circulating immunity and tumor microenvironment in patients with pancreatic ductal adenocarcinoma
Published 2025-03-01Subjects: “…|pancreatic ductal adenocarcinoma (pdac)|circulating immunity|tumor microenvironment (tme)|t cell subset…”
Get full text
Article -
4
Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
5
Radiotherapy and immune microenvironment crosstalk in pancreatic cancer: a comprehensive review of current insights and future directions
Published 2025-07-01Subjects: “…pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
6
Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatment
Published 2025-02-01Subjects: Get full text
Article -
7
Development and validation of a CT-measured body composition radiomics model for prognostic assessment in resected pancreatic adenocarcinoma
Published 2025-08-01Subjects: “…Pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
8
Immune checkpoint inhibitors in pancreatic adenocarcinoma: a systematic review and meta analysis of clinical outcomes
Published 2025-08-01Subjects: “…pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
9
Precision Medicine: IL-1RA and Pancreatic Cancer Organoids
Published 2025-05-01Subjects: Get full text
Article -
10
PD-L1 levels, TP53 mutation profiles, and survival outcomes in pancreatic cancer differ by immune-nutritional status
Published 2025-04-01Subjects: Get full text
Article -
11
Identification of key genes and pathways in the following pancreatic ductal adenocarcinoma (PDAC) using integrated bioinformatics analysis
Published 2025-07-01Subjects: “…Pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
12
-
13
Homologous recombination-DNA damage response defects increase TMB and neoantigen load, but not effector T cell density and clonal diversity in pancreatic cancer
Published 2025-06-01Subjects: “…Pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
14
Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in murine pancreatic cancer
Published 2025-07-01Subjects: “…Pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Article -
15
20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters
Published 2025-07-01Subjects: Get full text
Article -
16
Development of a Machine‐Learning Model for Diagnosis of Pancreatic Cancer from Serum Samples Analyzed by Thermal Liquid Biopsy
Published 2025-01-01Subjects: Get full text
Article